Latest common stock for NDRAW: $150.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
ENDRA Life Sciences- Warrants (12/05/2022) (NDRAW) currently reports a common stock of $150 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore ENDRA Life Sciences- Warrants (12/05/2022)'s common stock history and peer comparisons.
ENDRA Life Sciences- Warrants (12/05/2022)'s common stock changed from $0 to $150 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
ENDRA Life Sciences- Warrants (12/05/2022) reported $150 in common stock as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $150, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ENDRA Life Sciences- Warrants (12/05/2022), and consider following NDRAW for alerts when major investors trade the stock.
ENDRA Life Sciences- Warrants (12/05/2022) is classified in the Technology sector. On common stock, it currently shows $150. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing NDRAW with unrelated industries.